NCT02002793

Brief Summary

This study aims to standardized the process of mini-invasive abdominal draniage of SAP in early stage.To determine the indications and occasion.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2013

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

November 11, 2013

Completed
25 days until next milestone

First Posted

Study publicly available on registry

December 6, 2013

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2016

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2017

Completed
Last Updated

December 6, 2013

Status Verified

December 1, 2013

Enrollment Period

3.1 years

First QC Date

November 11, 2013

Last Update Submit

December 1, 2013

Conditions

Keywords

pancreatitisearly stagemini-invasive abdominal drainage

Outcome Measures

Primary Outcomes (1)

  • Rates of ACS in 28 days since outbreaks

    Time of first attacks of these situations that have to be surgically interfered in 28 days since onsets: ACS or pancreatic necrosis, abdominal hemorrhage, pancreatic abscess or pancreatic pseudocyst which brings symptoms or complications or increase in size;rates of organs' dysfunction, abdominal infection and reuse of drainage;

    28 days

Secondary Outcomes (1)

  • Rates of surgical interfere, MODS or death in 6 months since outbreaks

    6 months

Study Arms (2)

Early stage abdominal drainage

OTHER

SAP patients who matches one of the following criteria:1.Intravesical pressure≥20cmH2O or 2.CT images:acute peripancreatic liquid collection should have early stage abdominal drainage immediately;

Other: Early stage abdominal drainage

Late stage abdominal drainage

OTHER

Despite that it matches one of the cirteria as the study group:1.Intravesical pressure≥20cmH2O or 2.CT images:acute peripancreatic liquid collection, the patients continue acquire prearranged integrative treatment and will not accept early stage abdominal drainage until any of the followings emerge:1.Intra-abdominal apartment syndrome; 2. Pancreatic pseudocyst;3. Pancreatic or peripancreatic necrosis;

Other: Late stage abdominal drainage

Interventions

Ultrasound/CT/GUS guided abdominocentesis and drainage with single-chamber deep venous catheters shoule be implemented and the catheter should be removed when abdominal drainage flow≤100ml in two successive days;

Early stage abdominal drainage

Despite that it matches one of the cirteria as the study group:1.Intravesical pressure≥20cmH2O or 2.CT scan:acute peripancreatic liquid collection, the patients continue acquire prearranged integrative treatment and will not accept early stage abdominal drainage until any of the followings emerge:1.Intra-abdominal apartment syndrome; 2. Pancreatic pseudocyst;3. Pancreatic or peripancreatic necrosis;

Late stage abdominal drainage

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of pancreatitis 2.Onset of abdominal pain within 72h 3.Moderate severe or severe AP according to Atlanta criteria revisited in 2012 4.Intravesical pressure≥20cmH2O 4.CT images:acute peripancreatic liquid collection

You may not qualify if:

  • Pregnancy 2.Heart function: NYHA \>II 3.Pacemaker implantation 4.COPD 5.CKD 6.Pre-existing disease with life expectancy \< 3 months 7.CT images:No acute peripancreatic liquid collection 8.Intravesical pressure\>25cmH2O 9.At least one organ'S newly emerged dysfunction

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ruijin

Shanghai, Shanghai Municipality, 20000, China

RECRUITING

MeSH Terms

Conditions

Pancreatitis

Condition Hierarchy (Ancestors)

Pancreatic DiseasesDigestive System Diseases

Study Officials

  • erzhen Chen, Professor

    Emergency intensive care unit of Ruijin Hospital

    STUDY DIRECTOR

Central Study Contacts

erzhen Chen, PhD

CONTACT

enqiang Mao, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 11, 2013

First Posted

December 6, 2013

Study Start

August 1, 2013

Primary Completion

September 1, 2016

Study Completion

August 1, 2017

Last Updated

December 6, 2013

Record last verified: 2013-12

Locations